TARA MOLLUS: Open Payments
NPI 1437613049 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,021 in 101 payments from 35 companies in 2025. Trend: 2023 $1,977 · 2024 $2,857 · 2025 $2,021
Food & beverage: $1,941Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $180 |
| Novartis Pharmaceuticals Corporation | 7 | $146 |
| ABBVIE INC. | 6 | $141 |
| Merck Sharp & Dohme LLC | 7 | $125 |
| AstraZeneca Pharmaceuticals LP | 6 | $105 |
| Genentech USA, Inc. | 5 | $97 |
| Daiichi Sankyo Inc. | 6 | $95 |
| ARRAY BIOPHARMA INC | 4 | $94 |
| SEAGEN INC. | 1 | $80 |
| PFIZER INC. | 5 | $79 |
Products named: Enhertu, KEYTRUDA, ELAHERE, BRUKINSA, LYNPARZA, Epkinly, MONJUVI, QINLOCK.
Industry payments across AL — which companies pay providers there.
